← Back to Search

Care Partner Assessment Tool for Dementia

N/A
Recruiting
Led By Beth Fields, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours post-discharge
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at whether a care partner questionnaire can help people with dementia get better care when they leave the hospital. Care partners of hospitalized dementia patients take part in the trial for 14 days.

Who is the study for?
This trial is for adult care partners who provide unpaid assistance to a hospitalized relative or partner with Alzheimer's disease or related dementias (ADRD). Participants must be over 18 and speak English. It's not suitable for those who cannot communicate in English.
What is being tested?
The study is testing the CHAT-AD, an assessment tool designed to improve post-hospital care for people with dementia. Care partners will use this questionnaire to help ensure better ongoing care once the patient returns home from the hospital.
What are the potential side effects?
Since this trial involves using a questionnaire tool rather than medication, there are no direct medical side effects. However, participants may experience emotional or psychological stress while discussing sensitive topics about their caregiving experiences.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours post-discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 72 hours post-discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Care partner satisfaction of care
Change in Preparedness for Caregiving
Secondary study objectives
Change in care partner burden
Change in care partner depression
Feasibility measure: Implementation satisfaction
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Adjusted CHAT-ADExperimental Treatment1 Intervention
Using CHAT, participants will be asked questions about their needs to fully support and care for their loved one after the loved one is released from the hospital.
Group II: Standard of CareActive Control1 Intervention
Participants in this arm will only receive standard of care.

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,811 Previous Clinical Trials
8,161,130 Total Patients Enrolled
23 Trials studying Dementia
12,856 Patients Enrolled for Dementia
University of Wisconsin, MadisonLead Sponsor
1,228 Previous Clinical Trials
3,198,410 Total Patients Enrolled
8 Trials studying Dementia
1,708 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,785 Previous Clinical Trials
28,184,608 Total Patients Enrolled
292 Trials studying Dementia
23,634,745 Patients Enrolled for Dementia

Media Library

Adjusted CHAT-AD Clinical Trial Eligibility Overview. Trial Name: NCT05592366 — N/A
Dementia Research Study Groups: Standard of Care, Adjusted CHAT-AD
Dementia Clinical Trial 2023: Adjusted CHAT-AD Highlights & Side Effects. Trial Name: NCT05592366 — N/A
Adjusted CHAT-AD 2023 Treatment Timeline for Medical Study. Trial Name: NCT05592366 — N/A
~85 spots leftby May 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top